The nation of Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive data.
This rejection was revealed after a official document dated December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesman has since clarified that the United States was requesting genetic material for scientific study and profit but was not willing to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged more negotiations to reach a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Implications
This rejection follows a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.
According to statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our people should a new health crisis emerge."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting frameworks already set up through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This system is designed to ensure that when a nation contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how future collaboration could be designed in a manner that honours the independence and dignity of both nations."
Health Experts Response
A leading public health body said it recognised the official position, but suggested that negotiations should continue considering a large portion of the nation's Aids initiatives depended on external financing.
"Where specific concerns exist, such as those involving data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group added.
The situation highlights the complex tensions between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.